Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00366314 · ClinicalTrials.gov registry record
Frequency of Accessing Central Lines for Blood Samples
A clinical trial, sponsored by Children's Healthcare of Atlanta.
- Terminated
- Registry status
- 320
- Enrollment target
NCT00366314: Clinical Trial study, sponsored by Children's Healthcare of Atlanta.
NCT00366314 is a clinical trial that was terminated before completion, run by Children's Healthcare of Atlanta. The registered enrollment target is 320 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00366314 was terminated before completion, sponsored by Children's Healthcare of Atlanta.
- TERMINATED
- Registry status
- 320 participants
- Enrollment target
Study Summary
The purpose of this study is to quantify and analyze the line accesses for each of the 3 participating ICUs. The hypothesis is that the CICU will have a significantly higher number of line accesses than the other units. Analyzing the data will assist the researchers in identifying best practices and ultimately, reduce the BSI rate in the CICU.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Start Date | 2003-06 |
Why NCT00366314 stopped before completion
NCT00366314 is an observational study that tracks outcomes without assigning an intervention. The registered 320 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00366314 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00366314 about?
NCT00366314 is a clinical study titled "Frequency of Accessing Central Lines for Blood Samples". The purpose of this study is to quantify and analyze the line accesses for each of the 3 participating ICUs. The hypothesis is that the CICU will have a significantly higher number of line accesses than the other units. Analyzing the data will assist the researchers in identifying best practices an...
What is the current status of trial NCT00366314?
This trial is currently terminated. The enrollment target is 320 participants. The study started on 2003-06.
Who is sponsoring clinical trial NCT00366314?
This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02763683 · 320 participants
Investigations of Dementia in Parkinson Disease
- NCT03331198 · 320 participants · Phase 1
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
- NCT03458832 · 320 participants
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
- NCT03551951 · 320 participants
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia